Establishment Labs Holdings

ESTA · NASDAQ

$63.80+$0.28 (+0.44%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $63.52

Latest news

Press releaseOct 19, 8:00 AM ETBusiness Wire
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29
NewsOct 6, 3:43 AM ET
Establishment Labs Hldgs Reports Q2 2026 Results: Full Earnings Call Transcript
Press releaseOct 5, 8:00 AM ETBusiness Wire
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®
Press releaseSep 21, 8:00 AM ETBusiness Wire
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
Press releaseSep 1, 11:37 AM ETPRNewswire
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
Press releaseAug 12, 9:15 AM ETGlobe Newswire
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
Press releaseAug 6, 8:00 AM ETBusiness Wire
Establishment Labs® Reports Second Quarter 2026 Financial Results
NewsJul 31, 8:35 AM ETAvi Kapoor
Jim Cramer: Bending Spoons Is A ‘Really Good’ Software Company, Recommends Buying This Industrial Stock
Press releaseJul 23, 8:00 AM ETBusiness Wire
Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6
Press releaseJul 1, 9:05 AM ETGlobe Newswire
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
Press releaseJun 29, 8:00 AM ETBusiness Wire
Establishment Labs® Appoints Taylor Harris to Board of Directors
Press releaseJun 25, 9:04 AM ETGlobe Newswire
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
Press releaseJun 25, 8:00 AM ETBusiness Wire
Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index
Press releaseJun 16, 8:15 AM ETPRNewswire
Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
Press releaseMay 27, 9:00 AM ETGlobe Newswire
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Press releaseMay 22, 11:30 AM ETGlobe Newswire
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
NewsMay 6, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session
NewsMay 6, 9:31 AM ET
Establishment Labs Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript
Press releaseMay 6, 8:00 AM ETBusiness Wire
Establishment Labs Reports First Quarter 2026 Financial Results
Press releaseApr 30, 8:53 AM ETBusiness Wire
Establishment Labs® Refinances Credit Facility
Press releaseApr 23, 8:00 AM ETBusiness Wire
Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6
Press releaseApr 7, 8:00 AM ETBusiness Wire
Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market
NewsFeb 25, 1:01 PM ET
Breaking Down Establishment Labs Hldgs: 11 Analysts Share Their Views
NewsFeb 24, 8:02 AM ET
Establishment Labs Hldgs Earnings Review: Q4 Summary
Press releaseFeb 24, 8:00 AM ETBusiness Wire
Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
Press releaseFeb 24, 8:00 AM ETBusiness Wire
Establishment Labs Announces Leadership Transition to Support Next Phase of Growth
Press releaseFeb 18, 8:00 AM ETBusiness Wire
Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference
Press releaseFeb 10, 8:00 AM ETBusiness Wire
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24
Press releaseJan 12, 8:00 AM ETBusiness Wire
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Press releaseDec 31, 8:00 AM ETBusiness Wire
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
Press releaseDec 29, 8:00 AM ETBusiness Wire
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
NewsAug 20, 10:00 AM ET
Forecasting The Future: 4 Analyst Projections For Establishment Labs Hldgs
NewsJul 16, 9:06 AM ET
Deep Dive Into Establishment Labs Hldgs Stock: Analyst Perspectives (4 Ratings)
NewsOct 1, 3:01 PM ET
Critical Insights From Establishment Labs Hldgs Analyst Ratings: What You Need To Know
NewsSep 27, 6:46 AM ETAvi Kapoor
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

Establishment Labs Hldgs Reports Q2 2026 Results: Full Earnings Call Transcript

Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®

Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

Establishment Labs® Reports Second Quarter 2026 Financial Results

Jim Cramer: Bending Spoons Is A ‘Really Good’ Software Company, Recommends Buying This Industrial Stock

Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

Establishment Labs® Appoints Taylor Harris to Board of Directors

The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It

Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index

Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself

Earnings Scheduled For May 6, 2026

10 Health Care Stocks Whale Activity In Today's Session

Establishment Labs Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript

Establishment Labs Reports First Quarter 2026 Financial Results

Establishment Labs® Refinances Credit Facility

Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6

Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market

Breaking Down Establishment Labs Hldgs: 11 Analysts Share Their Views

Establishment Labs Hldgs Earnings Review: Q4 Summary

Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Establishment Labs Announces Leadership Transition to Support Next Phase of Growth

Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference

Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24

Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

Forecasting The Future: 4 Analyst Projections For Establishment Labs Hldgs

Deep Dive Into Establishment Labs Hldgs Stock: Analyst Perspectives (4 Ratings)

Critical Insights From Establishment Labs Hldgs Analyst Ratings: What You Need To Know

Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket